These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24472364)

  • 1. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.
    Ali AK
    Ann Epidemiol; 2014 Apr; 24(4):279-85. PubMed ID: 24472364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious adverse events with infliximab: analysis of spontaneously reported adverse events.
    Hansen RA; Gartlehner G; Powell GE; Sandler RS
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):729-35. PubMed ID: 17481964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study.
    Zannas AS; Okuno Y; Doraiswamy PM
    Pharmacotherapy; 2014 Mar; 34(3):272-8. PubMed ID: 24127392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
    Ali AK; Watson DE
    Pharmacotherapy; 2017 Nov; 37(11):1383-1390. PubMed ID: 28950039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Ali AK; Heran BS; Etminan M
    Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome in patients treated with immune checkpoint inhibitors.
    Fan Q; Hu Y; Wang X; Zhao B
    J Neurol; 2021 Jun; 268(6):2169-2174. PubMed ID: 33475824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
    Arabyat RM; Raisch DW; McKoy JM; Bennett CL
    Expert Opin Drug Saf; 2015; 14(11):1653-60. PubMed ID: 26393387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D; Menschik D; Bryant-Genevier M; Ball R
    Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.
    Baksh SN; McAdams-DeMarco M; Segal JB; Alexander GC
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):660-667. PubMed ID: 29655237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS).
    Ali AK
    Int J Organ Transplant Med; 2013; 4(2):62-71. PubMed ID: 25013655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.
    Orogun L; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(2):87-99. PubMed ID: 37154187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association of Guillain-Barré syndrome with vaccinations.
    Baxter R; Bakshi N; Fireman B; Lewis E; Ray P; Vellozzi C; Klein NP
    Clin Infect Dis; 2013 Jul; 57(2):197-204. PubMed ID: 23580737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.
    Souayah N; Michas-Martin PA; Nasar A; Krivitskaya N; Yacoub HA; Khan H; Qureshi AI
    Vaccine; 2011 Jan; 29(5):886-9. PubMed ID: 20869467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
    Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
    Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system.
    Nicholls C; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(1):63-73. PubMed ID: 35491805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.
    Napoli AA; Wood JJ; Coumbis JJ; Soitkar AM; Seekins DW; Tilson HH
    J Int AIDS Soc; 2014; 17(1):19214. PubMed ID: 25192857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.